216 related articles for article (PubMed ID: 23100145)
1. Simultaneous positivity for anti-DNA, anti-nucleosome and anti-histone antibodies is a marker for more severe lupus nephritis.
Sui M; Lin Q; Xu Z; Han X; Xie R; Jia X; Guo X; Zhang W; Guan X; Ren H
J Clin Immunol; 2013 Feb; 33(2):378-87. PubMed ID: 23100145
[TBL] [Abstract][Full Text] [Related]
2. Co-Positivity for Anti-dsDNA, -Nucleosome and -Histone Antibodies in Lupus Nephritis Is Indicative of High Serum Levels and Severe Nephropathy.
Yang J; Xu Z; Sui M; Han J; Sun L; Jia X; Zhang H; Han C; Jin X; Gao F; Liu Y; Li Y; Cao J; Ling H; Zhang F; Ren H
PLoS One; 2015; 10(10):e0140441. PubMed ID: 26465327
[TBL] [Abstract][Full Text] [Related]
3. Reactivity in ELISA with DNA-loaded nucleosomes in patients with proliferative lupus nephritis.
Dieker J; Schlumberger W; McHugh N; Hamann P; van der Vlag J; Berden JH
Mol Immunol; 2015 Nov; 68(1):20-4. PubMed ID: 26597199
[TBL] [Abstract][Full Text] [Related]
4. Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study.
Manson JJ; Ma A; Rogers P; Mason LJ; Berden JH; van der Vlag J; D'Cruz DP; Isenberg DA; Rahman A
Arthritis Res Ther; 2009 Oct; 11(5):R154. PubMed ID: 19828047
[TBL] [Abstract][Full Text] [Related]
5. Significance of co-positivity for anti-dsDNA, -nucleosome, and -histone antibodies in patients with lupus nephritis.
Choi SE; Park DJ; Kang JH; Lee SS
Ann Med; 2023 Dec; 55(1):1009-1017. PubMed ID: 36896834
[TBL] [Abstract][Full Text] [Related]
6. Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis.
Bruschi M; Moroni G; Sinico RA; Franceschini F; Fredi M; Vaglio A; Cavagna L; Petretto A; Pratesi F; Migliorini P; Locatelli F; Pazzola G; Pesce G; Bagnasco M; Manfredi A; Ramirez GA; Esposito P; Murdaca G; Negrini S; Cipriani L; Trezzi B; Emmi G; Cavazzana I; Binda V; Fenaroli P; Pisani I; Garibotto G; Montecucco C; Santoro D; Scolari F; Mosca M; Tincani A; Candiano G; Prunotto M; Volpi S; Verrina E; Angeletti A; Ravelli A; Ghiggeri GM
Rheumatology (Oxford); 2021 Jul; 60(7):3176-3188. PubMed ID: 33374003
[TBL] [Abstract][Full Text] [Related]
7. Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study.
Bruschi M; Moroni G; Sinico RA; Franceschini F; Fredi M; Vaglio A; Cavagna L; Petretto A; Pratesi F; Migliorini P; Locatelli F; Pazzola G; Pesce G; Bagnasco M; Manfredi A; Ramirez GA; Esposito P; Murdaca G; Negrini S; Cipriani L; Trezzi B; Emmi G; Cavazzana I; Binda V; d'Alessandro M; Fenaroli P; Pisani I; Garibotto G; Montecucco C; Santoro D; Scolari F; Volpi S; Mosca M; Tincani A; Candiano G; Prunotto M; Verrina E; Angeletti A; Ravelli A; Ghiggeri GM
Rheumatology (Oxford); 2021 Jul; 60(7):3388-3397. PubMed ID: 33351137
[TBL] [Abstract][Full Text] [Related]
8. Analysis of immunity index and immunopathogenesis pattern of lupus nephritis patients.
Gao JX; Diao HL; Liu YQ; Lv M; Dong H; Zhang XM; Wang YN
J Biol Regul Homeost Agents; 2015; 29(1):201-6. PubMed ID: 25864759
[TBL] [Abstract][Full Text] [Related]
9. Association of anti-nuclesome and anti C1q antibodies with lupus nephritis in an Egyptian cohort of patients with systemic lupus erythematosus.
Metwally IM; Eesa NN; Yacoub MH; Elsman RM
Adv Rheumatol; 2019 Mar; 59(1):10. PubMed ID: 30832710
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
[TBL] [Abstract][Full Text] [Related]
11. Cut-off values of immunological tests to identify patients at high risk of severe lupus nephritis.
Gargiulo MLÁ; Khoury M; Gómez G; Grimaudo S; Suárez L; Collado MV; Sarano J
Medicina (B Aires); 2018; 78(5):329-335. PubMed ID: 30285925
[TBL] [Abstract][Full Text] [Related]
12. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
Pradhan VD; Patwardhan MM; Ghosh K
Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
[TBL] [Abstract][Full Text] [Related]
13. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
[TBL] [Abstract][Full Text] [Related]
14. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis.
van Bruggen MC; Kramers C; Walgreen B; Elema JD; Kallenberg CG; van den Born J; Smeenk RJ; Assmann KJ; Muller S; Monestier M; Berden JH
Nephrol Dial Transplant; 1997 Jan; 12(1):57-66. PubMed ID: 9027774
[TBL] [Abstract][Full Text] [Related]
15. An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study.
Ravirajan CT; Rowse L; MacGowan JR; Isenberg DA
Rheumatology (Oxford); 2001 Dec; 40(12):1405-12. PubMed ID: 11752513
[TBL] [Abstract][Full Text] [Related]
16. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity.
Emad G; Al-Barshomy SM
Saudi J Kidney Dis Transpl; 2020; 31(2):342-352. PubMed ID: 32394906
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies.
Gutiérrez-Adrianzén OA; Koutouzov S; Mota RM; das Chagas Medeiros MM; Bach JF; de Holanda Campos H
J Rheumatol; 2006 Aug; 33(8):1538-44. PubMed ID: 16783863
[TBL] [Abstract][Full Text] [Related]
18. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
Quattrocchi P; Barrile A; Bonanno D; Giannetto L; Patafi M; Tigano V; Ferlazzo B
Reumatismo; 2005; 57(2):109-13. PubMed ID: 15983634
[TBL] [Abstract][Full Text] [Related]
19. Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study.
Bourse Chalvon N; Orquevaux P; Giusti D; Gatouillat G; Tabary T; Tonye Libyh M; Chrusciel J; Drame M; Stockton-Bliard G; Amoura Z; Arnaud L; Lorenz HM; Blaison G; Bonnotte B; Magy-Bertrand N; Revuz S; Voll RE; Hinschberger O; Schwarting A; Pham BN; Martin T; Pennaforte JL; Servettaz A
Front Immunol; 2020; 11():597863. PubMed ID: 33381119
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone.
Grootscholten C; Dieker JW; McGrath FD; Roos A; Derksen RH; van der Vlag J; Daha MR; Berden JH
Ann Rheum Dis; 2007 May; 66(5):693-6. PubMed ID: 17135217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
